id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-E-0117-0003,FDA,FDA-2001-E-0117,Determination of Regulatory Review Period for Purposes of Patent Extension; MIFEREX; Amendment - Notice,Notice,N-Notice,2002-10-25T04:00:00Z,2002,10,,,2010-03-12T16:13:43Z,,0,0,09000064804bbeec
FDA-2001-E-0117-0002,FDA,FDA-2001-E-0117,Determination of Regulatory Review Period for Purposes of Patent Extension; MIFEREX; Extension of Comment Period - Notice of Extension,Notice,NEC-Notice of Extension,2002-04-17T04:00:00Z,2002,4,2002-04-17T04:00:00Z,2002-04-27T03:59:59Z,2010-03-12T14:34:19Z,,0,0,09000064804bbe9b
FDA-2001-E-0117-0001,FDA,FDA-2001-E-0117,Determination of Regulatory Review Period for Purposes of Patent Extension; MIFEREX - Notice,Notice,N-Notice,2002-01-29T05:00:00Z,2002,1,2002-01-29T05:00:00Z,2003-01-26T04:59:59Z,2010-03-12T14:02:58Z,,0,0,09000064804bbe1b